Yüklüyor......
Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
PURPOSE: To report our findings in an infant with Peters anomaly type II whose retinopathy of prematurity (ROP) was treated with an anti-VEGF agent and surgeries. CASE REPORT: A male infant weighing 548 g was born prematurely at 23 weeks and 1 day with corneal opacity and shallow anterior chambers i...
Kaydedildi:
| Yayımlandı: | Case Rep Ophthalmol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224264/ https://ncbi.nlm.nih.gov/pubmed/25408672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368298 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|